Be a Model Communicator and Sell Your Models to Anyone

Publisher： John Wiley & Sons Inc

E-ISSN： 2163-8306|4|5|275-276

ISSN： 2163-8306

Source： Cpt: Pharmacometrics & Systems Pharmacology, Vol.4, Iss.5, 2015-05, pp. : 275-276

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bristol-Myers Squibb has announced that it will no longer make or sell the antidepressant Serzone

By  

Reactions Weekly, Vol. 1, Iss. 1007, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Teva Pharmaceutical Industries has decided not to sell generic Lipitor [atorvastatin] in the US

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 655, 2012-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

The lasso—a novel method for predictive covariate model building in nonlinear mixed effects models

By Ribbing Jakob   Nyberg Joakim   Caster Ola   Jonsson E.  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 34, Iss. 4, 2007-08 ,pp. : 485-517

Springer Publishing Company

Access to resources Recommend Favorite

BENZENE LEUKEMOGENESIS: AN ENVIRONMENTAL CARCINOGEN-INDUCED TISSUE-SPECIFIC MODEL OF NEOPLASIA USING GENETICALLY ALTERED MOUSE MODELS

By French John Edgar   Saulnier Muriel  

Journal of Toxicology and Environmental Health, Vol. 61, Iss. 5-6, 2000-11 ,pp. : 377-379

Taylor & Francis Ltd

Access to resources Recommend Favorite

Mixture Model Framework Facilitates Understanding of Zero-Inflated and Hurdle Models for Count Data

By Baughman A. L.  

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 5, 2007-09 ,pp. : 943-946

Taylor & Francis Ltd

Access to resources Recommend Favorite